BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 6413307)

  • 1. Metabolic aspects and viability of heparin/CPDA-1-stored red cell concentrate as a by-product of a high-yield factor VIII production method.
    de Jonge J; Smit Sibinga CT; Das PC
    Haemostasis; 1983; 13(4):214-8. PubMed ID: 6413307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of adenosine triphosphate and 2,3-diphosphoglycerate after twenty-four hours in red cells washed for neonatal transfusion.
    Wrotnowski U; Gray LS; Anderson G; Samsell JE; Mintz PD
    Vox Sang; 1988; 54(2):71-3. PubMed ID: 3376466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo regeneration of red cell 2,3-diphosphoglycerate following transfusion of DPG-depleted AS-1, AS-3 and CPDA-1 red cells.
    Heaton A; Keegan T; Holme S
    Br J Haematol; 1989 Jan; 71(1):131-6. PubMed ID: 2492818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival and biochemical characteristics of stored red cells preserved with citrate-phosphate-dextrose-adenine-one and two and prepared from whole blood maintained at 20 to 24 degrees C for eight hours following phlebotomy.
    Moroff G; Morse EE; Katz AJ; Kahn RA; Dende D; Swatman L; Staggs SD
    Transfusion; 1984; 24(2):115-9. PubMed ID: 6710583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Storage of red cell concentrates in CPD-A2 for 42 and 49 days.
    Beutler E; West C
    J Lab Clin Med; 1983 Jul; 102(1):53-62. PubMed ID: 6854134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of canine red blood cells stored in a saline, adenine, and glucose solution for 35 days.
    Wardrop KJ; Tucker RL; Mugnai K
    J Vet Intern Med; 1997; 11(1):5-8. PubMed ID: 9132483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dihydroxyacetone, pyruvate, and phosphate effects on 2,3 DPG and ATP in citrate-phosphate-dextrose-adenine blood preservation.
    Dawson RB; Fagan DS; Meyer DR
    Transfusion; 1984; 24(4):327-9. PubMed ID: 6464157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The storage of hard-packed red blood cells in citrate-phosphate-dextrose (CPD) and CPD-adenine (CPDA-1).
    Beutler E; West C
    Blood; 1979 Jul; 54(1):280-4. PubMed ID: 444671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viability and function of red blood cell concentrates stored at 4 degrees C for 35 days in CPDA-1, CPDA-2, or CPDA-3.
    Valeri CR; Valeri DA; Gray A; Melaragno A; Dennis RC; Emerson CP
    Transfusion; 1982; 22(3):210-6. PubMed ID: 7090034
    [No Abstract]   [Full Text] [Related]  

  • 10. Characterization of biochemical changes occurring during storage of red cells. Comparative studies with CPD and CPDA-1 anticoagulant-preservative solutions.
    Moroff G; Dende D
    Transfusion; 1983; 23(6):484-9. PubMed ID: 6649025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Red cell storage for 56 days in modified DPD-adenine. An in vitro evaluation.
    Moore GL; Ledford ME; Unruh KA; Brummell MR
    Transfusion; 1981; 21(6):699-701. PubMed ID: 7314217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of biochemical and functional alterations of rat and human erythrocytes stored in CPDA-1 for 29 days: implications for animal models of transfusion.
    d'Almeida MS; Jagger J; Duggan M; White M; Ellis C; Chin-Yee IH
    Transfus Med; 2000 Dec; 10(4):291-303. PubMed ID: 11123813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Red cell ATP and 2,3-diphosphoglycerate concentrations as a function of dihydroxyacetone supplementation of CPD adenine.
    Moore GL; Ledford ME; Brummell MR
    Vox Sang; 1981; 41(1):11-7. PubMed ID: 7324438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Refrigerated storage of lyophilized and rehydrated, lyophilized human red cells.
    Sowemimo-Coker SO; Goodrich RP; Zerez CR; Tanaka KR
    Transfusion; 1993 Apr; 33(4):322-9. PubMed ID: 8480352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The in vitro evaluation of modifications in CPD-adenine anticoagulated-preserved blood at various hematocrits.
    Moore GL; Ledford ME; Peck CC
    Transfusion; 1980; 20(4):419-26. PubMed ID: 7404640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A clinical evaluation of citrate-phosphate-dextrose-adenine blood.
    Kreuger A; Akerblom O; Högman CF
    Vox Sang; 1975; 29(2):81-9. PubMed ID: 807039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of irradiation on red cells stored in CPDA-1 and CPD-ADSOL (AS-1).
    Jeter EK; Gadsden RH; Cate J
    Ann Clin Lab Sci; 1991; 21(3):177-86. PubMed ID: 1905899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of additives on red cell 2,3 diphosphoglycerate levels in CPDA preservatives.
    Vora S; West C; Beutler E
    Transfusion; 1989; 29(3):226-9. PubMed ID: 2922791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Posttransfusion survival of red cells frozen for 8 weeks after 42-day liquid storage in AS-3.
    Rathbun EJ; Nelson EJ; Davey RJ
    Transfusion; 1989; 29(3):213-7. PubMed ID: 2922788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Manufacture of red cells in additive solution from whole blood refrigerated for 5 days or remanufactured from red cells stored in plasma.
    Wiltshire M; Cardigan R; Thomas S
    Transfus Med; 2010 Dec; 20(6):383-91. PubMed ID: 20681977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.